Roslin Tech is delighted to announce that Likarda, one of the leading regenerative medicine companies for companion animals, has extended its commercial partnership with us to continue developing advanced stem cell therapies for use in canines.
This extension will allow us to work together and continue to leverage our expertise and experience in the field of animal therapeutic developments to provide novel treatments for diabetes in companion animals. Likarda, a long-term partner of Roslin Tech, has a proven background in developing improved treatment options for companion animals using animal-derived stem cells for diseases or conditions than can be otherwise difficult to manage.
"We are thrilled to continue our collaboration with Roslin Tech. They possess an immense amount of knowledge and experience in the field of stem cells for veterinary applications, matched with an obvious passion to improve the lives of animals." said Lisa Stehno-Bittel, Ph.D., Likarda's President and Co-Founder.
“Combining the expertise of Roslin Tech's stem cell team with Likarda’s expertise in cell-based therapies is an exciting prospect. It is part of our mission at Roslin Tech to create partnerships like this, that will produce the future of veterinary therapeutics.” says Dr Joe Mee, Roslin Technologies Head of Laboratory Sciences.
Roslin Tech works with partners and specialists around the world to develop solutions for the emerging challenges in the veterinary and agricultural sectors. For more information, visit our website or contact info@roslintech.com.
